IL6 and cancer: Increasing evidence has shown that, upon inflammation, IL-6 activates STAT3 and exerts its predominant function in the regulation and maintenance of liver and colon CSCs [5, 27] However, the underlying molecular mechanisms and the IL-6/STAT3 downstream target genes that account for increased cancer stemness and malignancy are to date yet largely obscure.